10.1007/s12551-018-0496-2
If you have type 2 diabetes or another metabolic condition, medication changes may need closer monitoring because blood glucose targets before and during pregnancy are different from routine weight-loss goals
Overall, the study should compel clinicians to regularly assess a patients medications and determine if benefits still outweigh risks, especially in the setting of significant weight loss that might modify the need for those medications, Beverly G
As Stephen Lawrence, associate clinical professor at Warwick Medical School in Coventry, UK, points out when used in accordance with prescribed guidelines, it promotes weight loss in a safe and effective way for most people, and the treatment has already been used in T2DM
Frozen semaglutide is compromised and unsafe to inject
In major obesity trials, tirzepatide showed greater average weight loss, while semaglutide has an FDA-labeled cardiovascular risk-reduction benefit for certain patients and strong long-term clinical data